Dyne Therapeutics Inc (DYN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $16.19
• Market Cap: $2.65B
• EPS: $-3.75
• 52-Week High: $25.00
• 52-Week Low: $6.36

Market Sentiment

Dyne Therapeutics Inc currently has a Bullish sentiment score of 0.34.

About Dyne Therapeutics Inc

Dyne Therapeutics, Inc. is a cutting-edge biotechnology firm headquartered in Waltham, Massachusetts, focused on transforming the treatment landscape for genetically-driven muscle diseases. Utilizing its proprietary muscle-targeted delivery platform, the company is advancing a diverse pipeline of innovative therapeutic candidates designed to meet critical unmet medical needs in this specialized sector. With a commitment to developing impactful therapies, Dyne Therapeutics is poised to improve...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Dyne Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does DYN pay dividends?

Dyne Therapeutics Inc (DYN) does not currently pay a regular dividend.

What is DYN's market cap?

Dyne Therapeutics Inc (DYN) has a market capitalization of $2.65B with a current stock price of $16.19.